Issues and Challenges Surrounding Medical Countermeasure Development for Bioterrorism Dr Paul Russell Principal Medical Officer (Research), DSTL Porton.

Slides:



Advertisements
Similar presentations
FHM TRAINING TOOLS This training presentation is part of FHM’s commitment to creating and keeping safe workplaces. Be sure to check out all the training.
Advertisements

Hospital Pandemic Influenza Planning by Ed Lydon, CVPH.
Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
The Laboratory Response Network
Decontamination During Human Biological Incidents Presented by The Ohio Department of Health Disaster Preparedness & Response Program.
The Science of Agroterrorism Bob L. Larson, DVM, PhD, ACPVM University Extension, Commercial Agriculture Program, Beef Focus Team University of Missouri,
Placing Bioterrorism in its Context Dr. C. de Ville de Goyet.
ANTHRAX By: Justin Tursellino. Anthrax is a…. Anthrax is an infection caused by a bacterium, Bacillus anthracis. The infection can take three forms depending.
Overview of Auxiliary Distribution Plan NYC Department of Health and Mental Hygiene November 15, 2011.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.
Recommendations to Improve Dengue Control in the Philippines
Introduction to Forensic Epidemiology
Standardized Awareness Authorized Training, Train-the-Trainer Biological Agents.
Prevention and control of communicable disease. Over the last century, infectious diseases have lost a lot of their threat to individuals’ health as well.
Information on Agro/Bio terrorism Potential Occurrences and Emergency Management of Animal Diseases.
Health System Response to Pandemic Influenza: A Clinician's Perspective Mary M. Klote, MD Walter Reed Army Medical Center.
Vice Chancellor for RESEARCH Office of the Global Health is America’s Health and National Security Samuel L. Stanley, Jr., M.D. Paul Rogers Global Health.
Health Care Ethics and Bioterrorism 20 April 2004 Edward P. Richards Director, Program in Law, Science, and Public Health Louisiana State University Law.
Unmitigated Prejudice or Simple Negligence? The impact of biomedicine and EBM on pandemic influenza public policy Pharmaceuticals and Global Health: Inequalities.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Ohio Department of Health1 The State of Ohio Weapons of Mass Destruction BIO TERRORISM PROTOCOL PROCEDURES FOR LOCAL, STATE AND FEDERAL PERSONNEL AND AGENCIES.
From Pandemic Preparedness to Management: UK experience Professor Lindsey Davies CBE FRCP FFPH National Director of Pandemic Influenza Preparedness.
Enter Title of Presentation on Master Slide 1 Department of Health and Human Services (DHHS) Overview of FY04 DHHS Cooperative Agreements on Public Health.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Antiviral Stockpiling for Novel Strains of Influenza.
Non-Pharmaceutical Interventions to Face the Pandemic Dr John J. Jabbour Senior Epidemiologist IHR/CSR/DCD WHO/EMRO INTERCOUNTRY MEETING ON AVIAN INFLUENZA.
Microbial Threats to Health in the United States: Natural and Manmade Prof. Joshua Lederberg Raymond and Beverly Sackler Foundation Scholar Suite 400 (Founders.
Ebola Epidemic in Coastal West Africa – Overall Situation Report given at Caritas Internationalis Briefing Meeting 05 November 2014 Dr and Deacon Timothy.
Counter-terrorism at FDA Andrea Meyerhoff MD Director, Office of Counter-terrorism US Food and Drug Administration.
Emerging Diseases Lecture 7: Antibiotics 7.1 Overview 7.2 Dr. Ehrlich’s Magic Bullet 7.3 Sulfa drugs 7.4 Antibiotics 7.5 Disambiguation.
Food and Drug Administration
Assessing Hospital and Health System Preparedness and Response Nathaniel Hupert, M.D., M.P.H. Assistant Professor of Public Health and Medicine Division.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.8: Public Health Part II 1.8a: Public Health and Communicable Disease.
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
Public Health Preparedness Summer Institute for Public Health Practice August 4, 2003.
A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.
Terrorism & Bioterrorism Communication Challenges Module 9.
Emerging and Re-emerging Infectious Diseases Samantha Rosenthal, MPH, PhD Candidate.
PHEP Capabilities John Erickson, Special Assistant Washington State Department of Health
Chapter Six: Types of Modern Terrorism. Cyberterrorism.
Bioterrorism: The Threat Continues Byron Austin Jacob Norton Joseph Rooney The ripples of our background represent the spread of the disease throughout.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Biological Weapons A Counterterrorism Perspective University of California Lawrence Livermore National Laboratory J. Patrick Fitch, Ph.D. Program Leader.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Enter Title of Presentation on Master Slide U.S. Department of Health and Human Services Office of the Assistant Secretary for Public Health Emergency.
Is it Strategic Defense Initiative (SDI) – "Star War» ? No it is New Epi- demiological World- wide Strategic De- fense Initiative - (NEWSDI)
Biological Warfare -How biology involved in human conflict-
Infectious Diseases Emerging Threats. Beware respiratory symptoms August 14 th – a Friday informed of 4 cases all of whom had been hospitalised with respiratory.
Text 1 End Text 1 Learning Module 5: Surveillance and Infection Control.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
By: David Gonzales. What is Bioterrorism?  A bioterrorism attack is the deliberate release of viruses, bacteria, toxins or other harmful agents used.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness BIOLOGICAL AGENTS.
Presentation 1 Fairen Angelin, Samson M. Sc
Antibiotics: handle with care!
Biological Incidents Awareness
7.2 Dr. Ehrlich’s Magic Bullet
Biological agents that might be used as weapons of Bioterrorism
Expert Panel: Todd Damrow Cheryl Juntunen Susan Keady Michael Skeels
Infectious disease – a disease that is capable of being transmitted from one person to another by direct or indirect contact Starter Now think of as many.
ST. CLAIR COUNTY HEALTH DEPARTMENT EMERGENCY PREPAREDNESS AND RESPONSE
Medicine in third world countries
Introduction to public health surveillance
The Hong Kong Medical Association Symposium on Influenza 2003
Fig. 6.9.
Australian Civilian Military Cooperation
Presentation transcript:

Issues and Challenges Surrounding Medical Countermeasure Development for Bioterrorism Dr Paul Russell Principal Medical Officer (Research), DSTL Porton Down Consultant Medical Microbiology and Virology, Salisbury District Hospital Pharmaceuticals and Global Health: Inequalities and Innovation in the 21st Century

Who? And What? Individual(s) with individual agenda (“lone wolf”) -“Technically impoverished” -“Gifted amateur” Individual/group as part of organised network - De novo group - Faction/recognised Terrorist Group State sponsored Terrorist Group Hostile nation state Sophistication Agent Delivery Resources Financial Materiel People Scale of Production

Agents Anthrax Plague Tularemia Botulinum Brucella Venezualan Equine Encephalitis Smallpox Viral haemorrhagic fever

Reality…………?

Bhagwan Shree Rajneesh Sect 1984 Salmonella typhimurium Ordered from a collection Propagated by individuals with some technical skill Simple delivery 751 cases: 45 hospitalised: No fatalities Used to influence local elections Not discovered as deliberate release for a year after the incident

But…. Bacillus anthracis Alleged government scientist with mental health problems Potential 32,000 exposures 22 cases; 11 inhalational 5 deaths In the immediate aftermath of the September 11 th attacks FBI Investigation - "one of the largest and most complex in the history of law enforcement“ Over 6 continents 9,000 interviews 67 searches 6,000 subpoenas Cost of clean up in excess $1 billion $5.6 billion allocated over 10 years for vaccines and medical countermeasures

Deliberate release Disease outbreak from deliberate release is essentially the same as a natural outbreak –Point source –Disseminated cases as people disperse Secondary spread if transmissible Difficult to discriminate between the two –Unusual disease –Unusual presentation

Infectious Disease Outbreak As with any disease outbreak Multi-agency –NHS –DoH –PHE –DEFRA Implications but not necessarily direct involvement –Education, Home Office, MoD, Treasury and other national and local government departments/agencies

Deliberate Release Crime –Law enforcement agencies –Counter-terrorism –Security services Requirement for technical advice and forensic exploitation –Home Office –MoD –Foreign and Commonwealth Office

Deliberate Release - Challenges Political –Political pressure Repugnant act Who did it? Retaliation? “Something must be done” Social –Fear –Ignorance –Treating the sick – may be large numbers –Treating the well – will be even bigger numbers! –Social interventions Closing schools, restricting travel etc.

Medical Countermeasures – What? Bacterial infection can be treated with antibiotics –Which ones? –Route Difficult to establish intra-venous lines in large numbers of people Preferably oral –Problematic in patients with vomiting and/or diarrhoea ?Intra-muscular –Stock-piling Expensive Storage Drug shelf life – turnover and restock –Prophylaxis? –Timely administration Rapid onset of disease Too late once symptoms appear

Medical Countermeasures – What? Antivirals –Very few –Poor efficacy or paucity of evidence of efficacy against some of the viruses –Bioterrorism virus threats not likely to give an adequate financial return for research and licensing (e.g. compared to influenza or HIV) Vaccines –Very few –Where available Limited production and supply Non-licensed use –Ethics of vaccinating against “non-public health” threats –Acceptable to the population Influenza immunisation rates in healthcare staff!! –As with antiviral drugs little incentive to develop

Dstl Medical countermeasures to deliberate release agents on a background of expertise in working in high level microbiological containment –De novo vaccine research –Candidate vaccine testing in collaboration with other institutions –Antibiotic/antiviral efficacy Old and new antibiotics/antivirals –Generic countermeasures –Horizon scanning

Dstl Research coupled with –Diagnostics and detection to provide earliest opportunity to treat infection –Management of sepsis –Provide specialist advice to government to prevent the proliferation of biological weapons and maintain security of potential deliberate release agents –Collaborate nationally and internationally with academia and industry

The Biggest Bioterrorist of All……

………Is Mother Nature

Any questions?